The Australian market has shown resilience with the ASX200 closing up 0.18% at 8,300 points, buoyed by strong performances in the Staples and Utilities sectors. In this environment, identifying stocks that may be trading below their estimated value can provide opportunities for investors seeking to capitalize on potential market inefficiencies and sector-specific strengths. Top 10 Undervalued Stocks Based On Cash Flows In Australia Name Current Price Fair Value (Est) Discount (Est) Mader Group (ASX:MAD) A$6.68 A$13.22 49.5% Telix Pharmaceuticals (ASX:TLX) A$22.78 A$44.45 48.8% MLG Oz (ASX:MLG) A$0.57 A$1.12 49.2% Atlas Arteria (ASX:ALX) A$4.89 A$9.44 48.2% Ingenia Communities Group (ASX:INA) A$4.92 A$9.33 47.2% Vault Minerals (ASX:VAU) A$0.325 A$0.64 49.5% Millennium Services Group (ASX:MIL) A$1.145 A$2.24 48.9% Audinate Group (ASX:AD8) A$8.82 A$17.59 49.9% Energy One (ASX:EOL) A$5.94 A$10.77 44.8% FINEOS Corporation Holdings (ASX:FCL) A$2.03 A$3.83 47% Click here to see the full list of 39 stocks from our Undervalued ASX Stocks Based On Cash Flows screener. Let's explore several standout options from the results in the screener. Atlas Arteria Overview: Atlas Arteria Limited owns, develops, and operates toll roads with a market capitalization of A$7.12 billion. Operations: The company's revenue is primarily derived from its toll road operations, with contributions of A$1.70 billion from APRR, A$36.90 million from ADELAC, A$25.10 million from Warnow Tunnel, A$128.90 million from Chicago Skyway, and A$115 million from Dulles Greenway. Estimated Discount To Fair Value: 48.2% Atlas Arteria is trading at A$4.91, significantly below its estimated fair value of A$9.44, indicating it may be undervalued based on cash flows. Despite a forecasted revenue growth of 19.6% per year, which outpaces the Australian market's 5.7%, its dividend yield of 8.15% isn't well covered by earnings or free cash flows. Recent leadership changes with Hugh Wehby as CEO may impact strategic direction positively in the infrastructure sector. Our growth report here indicates Atlas Arteria may be poised for an improving outlook. Click to explore a detailed breakdown of our findings in Atlas Arteria's balance sheet health report.ASX:ALX Discounted Cash Flow as at Nov 2024 FINEOS Corporation Holdings Overview: FINEOS Corporation Holdings plc develops and sells enterprise claims and policy management software for the employee benefits and life, accident, and health insurance industries worldwide, with a market cap of A$656.34 million. Operations: The company's revenue primarily stems from its software and programming segment, which generated €122.24 million. Story Continues Estimated Discount To Fair Value: 47% FINEOS Corporation Holdings is trading at A$2.03, significantly below its estimated fair value of A$3.83, reflecting potential undervaluation based on cash flows. Despite a net loss of EUR 5.32 million for the first half of 2024, FINEOS expects revenue growth to outpace the Australian market at 9.7% annually and projects profitability within three years. Recent client acquisition with Voya Financial underscores its strong position in the insurance software sector despite being dropped from the S&P Global BMI Index. Our expertly prepared growth report on FINEOS Corporation Holdings implies its future financial outlook may be stronger than recent results. Click here and access our complete balance sheet health report to understand the dynamics of FINEOS Corporation Holdings.ASX:FCL Discounted Cash Flow as at Nov 2024 Nuix Overview: Nuix Limited offers investigative analytics and intelligence software solutions across various regions including Asia Pacific, the Americas, Europe, the Middle East, and Africa, with a market cap of A$2.02 billion. Operations: The company's revenue primarily comes from its Software & Programming segment, which generated A$220.62 million. Estimated Discount To Fair Value: 13% Nuix Limited, trading at A$6.20, is priced below its estimated fair value of A$7.13, suggesting potential undervaluation based on cash flows. The company recently turned profitable and forecasts robust earnings growth of 59.6% annually over the next three years, outpacing the Australian market average. However, shareholders faced dilution last year and Return on Equity is projected to be low at 11.9% in three years despite revenue growth surpassing market rates. The growth report we've compiled suggests that Nuix's future prospects could be on the up. Unlock comprehensive insights into our analysis of Nuix stock in this financial health report.ASX:NXL Discounted Cash Flow as at Nov 2024 Summing It All Up Click through to start exploring the rest of the 36 Undervalued ASX Stocks Based On Cash Flows now. Got skin in the game with these stocks? Elevate how you manage them by using Simply Wall St's portfolio, where intuitive tools await to help optimize your investment outcomes. Enhance your investing ability with the Simply Wall St app and enjoy free access to essential market intelligence spanning every continent. Ready To Venture Into Other Investment Styles? Explore high-performing small cap companies that haven't yet garnered significant analyst attention. Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence. Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include ASX:ALX ASX:FCL and ASX:NXL. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email [email protected] View Comments
ASX Stocks That May Be Trading Below Their Estimated Value In November 2024
You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research.
Start Your Free Trial Now!Not sure where to invest today?
Kalkine’s latest research highlights three companies identified through in-depth analysis and market insights.
Explore these research reports to learn about companies currently being tracked by our analysts and make more informed investment decisions.
View 3 Research ReportsThis information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.
Please wait processing your request...